Entry Detail


General Information

Database ID:TRD03773
Confidence:Median
Contents:>> tsRNA Information
>> tsRNA Association Statistics
>> Disease Information
>> Disease Association Statistics
>> Evidence Support
>> Reference



tsRNA Information

tsRNA Name:tsrna-02515
tsRNA Type:tRF-5
Amino acid and Anticodon:LysTTT
Sequence:CACTGTAAAGCTAACTTAGCATTAACCTTTTAAGTTAAAGATTAAGAGAA
Related Target:N/A
Predicted Target:IMPAD1//EIF5A2//LARP1B//ARL14EPL//HPSE//SOBP//SMARCAD1//AP5M1//KNTC1//FLRT2
External Links:
MINTbase ID:tRF-50-2YU04DYJIO3ZU3U0IO5B
tRFdb ID:N/A

[1] gtRNAdb_ID:-
Anticodon:LysTTT
tRNA_number:trnaMT
Chromosome:MT
Strand:+
Coordinate:Start Site(bp): 8295        End Site(bp): 8344

[2] gtRNAdb_ID:-
Anticodon:LysTTT
tRNA_number:trnalookalike7
Chromosome:1
Strand:+
Coordinate:Start Site(bp): 568844        End Site(bp): 568893



tsRNA Association Statistics

Total Associated Disease Number:2
More Information
Network:
(Display the first 15 nodes)



Disease Information

 MeSHDisease Ontology
Disease ID:D021441DOID:3498
Disease Name:Carcinoma, Pancreatic Ductalpancreatic ductal adenocarcinoma
Category:MeSHDisease Ontology
Type:Neoplasms//Digestive System Diseases//Endocrine System Diseasesdisease of anatomical entity//disease of cellular proliferation
Define:Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.A pancreatic adenocarcinoma that derives_from pancreatic duct cells.
Alias:Carcinoma, Ductal, Pancreatic//Duct-Cell Carcinoma of the Pancreas//Duct-Cell Carcinoma, Pancreas//Ductal Carcinoma of the Pancreas//Pancreatic Duct Cell Carcinoma//Pancreatic Ductal Carcinomaductal adenocarcinoma of the pancreas



Disease Association Statistics

Total Associated tsRNA Number:114
More Information
Network:
(Display the first 15 nodes)



Evidence Support

Strong Evidence:N/A
Weak Evidence:High-throughput sequencing



Reference

[1] PubMed ID:33791157
Disease Name:Carcinoma, Pancreatic Ductal
Tissue:Serum
Dysfunction Pattern:Up-Regulation
Validated Method:High-throughput sequencing
Description:There were 45 tsRNAs expressed at remarkably higher levels, 41 tsRNAs expressed at lower levels in PDAC patients, respectively, compared with healthy volunteers.
Comparision:Cancer VS Normal
Mechanism:N/A